» Articles » PMID: 15132968

Hedgehog Signaling Promotes Prostate Xenograft Tumor Growth

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2004 May 11
PMID 15132968
Citations 121
Authors
Affiliations
Soon will be listed here.
Abstract

During fetal prostate development, Sonic hedgehog (Shh) expression by the urogenital sinus epithelium activates Gli-1 expression in the adjacent mesenchyme and promotes outgrowth of the nascent ducts. Shh signaling is down-regulated at the conclusion of prostate ductal development. However, a survey of adult human prostate tissues reveals substantial levels of Shh signaling in normal, hyperplasic, and malignant prostate tissue. In cancer specimens, the Shh expression is localized to the tumor epithelium, whereas Gli-1 expression is localized to the tumor stroma. Tight correlation between the levels of Shh and Gli-1 expression suggests active signaling between the tissue layers. To determine whether Shh-Gli-1 signaling could be functionally important for tumor growth and progression, we performed experiments with the LNCaP xenograft tumor model and demonstrated that: 1). Shh expressed by LNCaP tumor cells activates Gli-1 expression in the tumor stroma, 2). genetically engineered Shh overexpression in LNCaP cells leads to increased tumor stromal Gli-1 expression, and 3). Shh overexpression dramatically accelerates tumor growth. These data suggest that hedgehog signaling from prostate cancer cells to the stroma can elicit the expression of paracrine signals, which promote tumor growth.

Citing Articles

Stromal androgen signaling governs essential niches in supporting prostate development and tumorigenesis.

Rhee J, Adzavon Y, Sun Z Oncogene. 2024; 43(47):3419-3425.

PMID: 39369165 PMC: 11573710. DOI: 10.1038/s41388-024-03175-1.


Identification of small molecule antagonists of sonic hedgehog/heparin binding with activity in hedgehog functional assays.

Lamson D, Tarpley M, Addo K, Ji X, Abu Rabe D, Ehe B Biochim Biophys Acta Gen Subj. 2024; 1868(11):130692.

PMID: 39151833 PMC: 11486593. DOI: 10.1016/j.bbagen.2024.130692.


Potential roles of FGF5 as a candidate therapeutic target in prostate cancer.

Stangis M, Colah A, McLean D, Halberg R, Collier L, Ricke W Am J Clin Exp Urol. 2023; 11(6):452-466.

PMID: 38148937 PMC: 10749387.


Targeting the hedgehog pathway in MET mutation cancers and its effects on cells associated with cancer development.

Du Y, Sun H, Shi Z, Sui X, Liu B, Zheng Z Cell Commun Signal. 2023; 21(1):313.

PMID: 37919751 PMC: 10623711. DOI: 10.1186/s12964-023-01333-8.


Influence of Long Non-Coding RNA in the Regulation of Cancer Stem Cell Signaling Pathways.

Sonawala K, Ramalingam S, Sellamuthu I Cells. 2022; 11(21).

PMID: 36359888 PMC: 9656902. DOI: 10.3390/cells11213492.